1Young RH, Scully RE. Metastatic tumors of the ovary. In : Kurman RJ. eds. Blaustein' s Gynecological pathology of the female genital tract [M]. 3rd edition. New Yolk : Springer, 1987 : 742 - 768.
2Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases [J]. Hum Pathol, 1985,16(1) :28 - 34.
5Eifel P, Hendrickson M, Ross J, et al. Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer, 1982,50 : 163-170.
6Lin WM, Forgacs E, Warshal DP, et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res, 1998, 4:2577-2583.
7Mcmeekin DS, Burger RA, Manetta A, et al. Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis.Gynecologic Oncology, 1995, 59:81-86.
8Falkenberry SS, Steinhoff MM,-Gordinier M, et al. Synchronous endometrioid tumors of the ovary and endometrium: a clinicopathologic study of 22 cases. J Reprod Med, 1996, 41 : 713-718.
9Scully RE, Young RH. Metastetic tumor of the ovary. In: Kurman RJ, eds. Blaustein's gynecologic pathology of the female genital tract. 3rd ed. New York: Springer, 1991. 742-749.
10Ricci R, Komminoth P, Bannwart F, Torhorst J, et al. PTEN as a molecular marke to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus. Diagn Mol Pathol,2003, 12:71-78.
